France· FR:65238711
MAXIDEX 0,1 POUR CENT, collyre
A medicinal product containing dexaméthasone, registered in France by NOVARTIS PHARMA, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DEXAMÉTHASONE
- Manufacturer
- NOVARTIS PHARMA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009306524731 flacon(s) polyéthylène de 3 mlEUR 1.09
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dexaméthasone in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDecadron 4mg tabletsCST Pharma Ltd
- United StatesdexamethasoneMajor Pharmaceuticals
- CzechiaDEXAMETHASONE KRKAKrka, d.d., Novo mesto, Novo mesto
- PolandCovexanZakłady Farmaceutyczne POLPHARMA S.A.
- GermanyDexaHexal Ag
- SpainAMEXXINE 1 MG/ML COLIRIO EN SOLUCIONPharmaselect International Beteiligungs Gmbh
- Japanデキサメタゾン日新製薬（山形）
- NetherlandsAxium-Opto 1mg/ml oogdruppels, oplossing in verpakking voor eenmalig gebruikUni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dexamethason Hcs, Dexamethason Kalceks
- Belgium · Darazon, Dexalis
- Bulgaria · Dexanova, Дeксаметазон Крка
- Cyprus · Axium-Opto, Decadron
- Czechia · Dexamed, Dexamethasone Fmk
- Germany · Dexa, Dexa Edo
- Denmark · Axiumopto, Dexacur
- Estonia · Caltrixan, Dexamethason Krka
- Spain · Amexxine, Dexafree
- Finland · Axiumopto, Dexacur
- United Kingdom (Northern Ireland) · Dexafree, Dexamethason Glenmark Pharmaceuticals Europe
- Greece · Amelinor, Axium
- Croatia · Darazur, Deksametazon Kalceks
- Hungary · Darazur, Dexamethasone Kalceks
- Ireland · Dexafree, Dexamethasone Activase Pharmaceuticals
- Iceland · Dexametason Abcur, Dexamethason Krka
- Italy · Amexzur, Cortmuper
- Liechtenstein · Neofordex, Ozurdex
- Lithuania · Dexamethason Krka, Dexamethasone Kalceks
- Luxembourg · Dexalis, Dexamethasone Kalceks
- Latvia · Dexamethason Krka, Dexamethasone Kalceks
- Malta · Axium-Opto, Decadron
- Netherlands · Axium-Opto, Dexamethason
- Norway · Dexacur, Dexametason Abcur
- Poland · Covexan, Darazur
- Portugal · Amexzur, Decadron
- Romania · Dexametazonă Fosfat Krka, Dexametazona Krka
- Sweden · Axiumopto, Baxil
- Slovenia · Deksametazon Krka, Deksametazon Medochemie
- Slovakia · Amexxine, Dexametazón Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e38a0c95-aae9-47c3-b144-c11de2c48e9e GET /v1/drugs/e38a0c95-aae9-47c3-b144-c11de2c48e9e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65238711",
"date_amm": "1992-10-27",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DEXAMÉTHASONE",
"statut_amm": "Autorisation active",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "collyre",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Non"
}See everything about dexaméthasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.